EOS imaging receives Chinese FDA approval for EOS system: 3 things to know

EOS imaging received approval from the China Food and Drug Administration to market the EOS system.

Advertisement

Here are three things to know:

 

1. The EOS system is already in clinical use in several markets in the Asia-Pacific region, including Hong Kong, Singapore, Japan, Australia and Vietnam.

 

2. With this new approval, the EOS system can be marketed in 51 countries worldwide.

 

3. The EOS system is a medical imaging system focused on osteoarticular pathologies and orthopedics.

 

More articles on devices:
Medtech, Life Spine, Zimmer Biomet & more: 20 key notes
Amedica’s product revenue drops 15% in 2015 to $19.5M: 7 key notes
Maxx Orthopedics’ Freedom PCK System successfully implanted in 1st surgeries: 4 points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.